Ignite Creation Date:
2024-05-06 @ 7:01 PM
Last Modification Date:
2024-10-26 @ 2:58 PM
Study NCT ID:
NCT05863273
Status:
NOT_YET_RECRUITING
Last Update Posted:
2023-05-18
First Post:
2023-05-09
Brief Title:
Real World Study on the Efficacy and Safety of Apremilast in Chinese Patients With Moderate to Severe Plaque Psoriasis a Multi Center Prospective Observational TrialREACT
Sponsor:
First Hospital of China Medical University
Organization:
First Hospital of China Medical University
Organization Data
Organization:
First Hospital of China Medical University
Class:
OTHER
Study ID:
OTL-A-2201
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
First Hospital of China Medical University
Lead Sponsor Class:
OTHER
Responsible Party:
Xing hua Gao
Responsible Party Title:
First Hospital of China Medical University
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
First Hospital of China Medical University
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| China-Japan Friendship Hospital | OTHER |